Mc. Hertl et al., INTRAFASCICULAR INJECTION OF AMMONIUM-SULFATE AND BUPIVACAINE IN PERIPHERAL-NERVES OF NEONATAL AND JUVENILE RATS, REGIONAL ANESTHESIA AND PAIN MEDICINE, 23(2), 1998, pp. 152-158
Background and Objectives. Regional nerve blocks are often used for th
e treatment of postoperative pain in children. Ammonium sulfate is a n
on-narcotic anesthetic agent, which has been reported to provide pain
relief lasting days to weeks, with few reported side effects in adult
studies. Prior to considering clinical use in children, the neurotoxic
ity of ammonium sulfate in 4-day and 3-week old rats was assessed and
compared with that of bupivacaine. Methods. Each rat received a poster
ior tibial nerve intrafascicular injection (0.01 mL in 4-day-old and 0
.02 mt in 3-week-old rats) using either 10% ammonium sulfate (n = 24 p
er age group), 0.5% bupivacaine (n = 18 per age group), 0.9% saline (n
= 18 per age group), or 5% phenol (n = 18 per age group). A functiona
l assessment by serial walking track analysis and a morphologic assess
ment by neurohistology were made. Results. No abnormalities in serial
walking track analysis and no structural nerve damage were detected af
ter ammonium sulfate, bupivacaine, or saline injection. Bupivacaine ca
used mild focal changes in both age groups, which recovered by 8 weeks
. Conclusions. Intrafascicular injection of ammonium sulfate was as sa
fe as bupivacaine in this animal model. Further animal studies must be
made before human trials are initiated.